Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sanaa M. Aly, Sylvie Deheul, Etienne Puymirat, Camille Richeval, Delphine Allorge & Jean-michel Gaulier. (2021) Takotsubo cardiomyopathy as a consequence of 4-fluoroamphetamine Mono-intoxication documented by toxicological analyses. Clinical Toxicology 59:1, pages 73-74.
Read now
Read now
Xander M. R. Van Wijk, Robert Goodnough & Jennifer M. Colby. (2019) Mass spectrometry in emergency toxicology: Current state and future applications. Critical Reviews in Clinical Laboratory Sciences 56:4, pages 225-238.
Read now
Read now
Articles from other publishers (30)
Eric J. Lavonas, Peter D. Akpunonu, Ann M. Arens, Kavita M. Babu, Dazhe Cao, Robert S. Hoffman, Christopher O. Hoyte, Maryann E. Mazer-Amirshahi, Andrew Stolbach, Maude St-Onge, Trevonne M. Thompson, George Sam Wang, Amber V. Hoover & Ian R. Drennan. (2023) 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation.
Crossref
Crossref
Matthew C. Hulme, Armita Hayatbakhsh, Rachel M. Brignall, Nicolas Gilbert, Andrew Costello, Christopher J. Schofield, David C. Williamson, E. Kate Kemsley, Oliver B. Sutcliffe & Ryan E. Mewis. (2021)
Detection, discrimination and quantification of amphetamine, cathinone and
nor
‐ephedrine regioisomers using benchtop
1
H and
19
F nuclear magnetic resonance spectroscopy
. Magnetic Resonance in Chemistry 61:2, pages 73-82.
Crossref
Crossref
Femke M. J. Gresnigt, Anouk Snik, Eric J. F. Franssen, Joost W. Vanhommerig, Dylan W. de Lange & Robert K. Riezebos. (2022) 4‐Fluoroamphetamine (4‐FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis. Journal of the American College of Emergency Physicians Open 3:5.
Crossref
Crossref
Maria Nieddu, Elena Baralla, Valeria Pasciu, Maria Grazia Rimoli & Gianpiero Boatto. (2022) Cross-reactivity of commercial immunoassays for screening of new amphetamine designer drugs. A review. Journal of Pharmaceutical and Biomedical Analysis 218, pages 114868.
Crossref
Crossref
Dimitri Gerostamoulos, Linda Glowacki, Maria Pricone, Kerryn Crump, Matthew Di Rago, Samantha Joubert, Matthew J Lynch, Noel W Woodford & Olaf H Drummer. (2022) Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. Journal of Analytical Toxicology.
Crossref
Crossref
Alicia Ramos-Rodriguez, Carmen Fernandez-Bravo, Lorena Estepa-Pedregosa & Moises Rodriguez-Gonzalez. (2022) The Pivotal Role of Echocardiography in the Diagnosis of Stress-Induced
Cardiomyopathy Presenting with Atypical Pattern in Critically Ill
Children. An Illustrative Case Report. Current Medical Imaging Formerly Current Medical Imaging Reviews 18:9, pages 1003-1011.
Crossref
Crossref
Emily Nash, Darren M. Roberts & Nazila Jamshidi. (2021) Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use. Cardiovascular Toxicology 21:12, pages 1012-1018.
Crossref
Crossref
Moritz Losacker, Stefan W Toennes, Elizabeth B de Sousa Fernandes Perna, Johannes G Ramaekers, Joerg Roehrich & Cornelius Hess. (2021) Chiral Serum Pharmacokinetics of 4-Fluoroamphetamine after Controlled Oral Administration: Can (R)/(S)-Concentration Ratios Help in Interpreting Forensic Cases?. Journal of Analytical Toxicology 45:9, pages 985-992.
Crossref
Crossref
Rita Roque Bravo, Helena Carmo, Maria João Valente, João Pedro Silva, Félix Carvalho, Maria de Lourdes Bastos & Diana Dias da Silva. (2021) 4-Fluoromethamphetamine (4-FMA) induces in vitro hepatotoxicity mediated by CYP2E1, CYP2D6, and CYP3A4 metabolism. Toxicology 463, pages 152988.
Crossref
Crossref
Yuko Ikematsu & Elizabeth Papathanassoglou. (2020) Altered Mental Status: An Exploration of Definitions and Descriptors in the Literature. Connect: The World of Critical Care Nursing 14:2, pages 97-111.
Crossref
Crossref
Stefan W. Toennes, David Schneider, Werner Pogoda, Alexander Paulke, Cora Wunder, Eef L. Theunissen, Elizabeth B. de Sousa Fernandes Perna & Johannes G. Ramaekers. (2020) Excretion of 4-fluoroamphetamine and three metabolites in urine after controlled oral ingestion. Journal of Pharmaceutical and Biomedical Analysis 179, pages 113008.
Crossref
Crossref
R.S.D. van der Pas, F.M.J. Gresnigt, L. Wansink, E.J.F. Franssen & R.K. Riezebos. (2020) Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual. Toxicology Reports 7, pages 1629-1633.
Crossref
Crossref
Michaël Cardinale, Pierre Esnault, Johan Schmitt & Eric Meaudre. (2019) Transient Left Ventricular Acute Failure after Cocaine Use. Current Drug Research Reviews 11:2, pages 142-144.
Crossref
Crossref
Stefan W. Toennes, David Schneider, Werner Pogoda, Alexander Paulke, Cora Wunder, Eef L. Theunissen, Kim P.C. Kuypers, Eliza Sousa Fernandes Perna & Johannes G. Ramaekers. (2019) Pharmacokinetic properties of 4‐fluoroamphetamine in serum and oral fluid after oral ingestion. Drug Testing and Analysis 11:7, pages 1028-1034.
Crossref
Crossref
C. H. W. Wijers, M. C. Visser, R. T. H. van Litsenburg, R. J. M. Niesink, R. B. Willemse & Esther A. Croes. (2018) Haemorrhagic stroke related to the use of 4-fluoroamphetamine. Journal of Neurology 265:7, pages 1607-1611.
Crossref
Crossref
Jennifer M Colby, Katie L Thoren & Kara L Lynch. (2018) Suspect Screening Using LC–QqTOF Is a Useful Tool for Detecting Drugs in Biological Samples. Journal of Analytical Toxicology 42:4, pages 207-213.
Crossref
Crossref
Laura Hondebrink, Johanna J. Nugteren–van Lonkhuyzen, Saskia J. Rietjens, Tibor M. Brunt, Bastiaan Venhuis, Vidija Soerdjbalie-Maikoe, Beitske E. Smink, Antoinette J.H.P. van Riel & Irma de Vries. (2018) Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study. Annals of Emergency Medicine 71:3, pages 294-305.
Crossref
Crossref
Anja BegemanEric J. F. Franssen. (2018) Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays. Therapeutic Drug Monitoring 40:1, pages 135-139.
Crossref
Crossref
Anne Zwartsen, Anouk H.A. Verboven, Regina G.D.M. van Kleef, Fiona M.J. Wijnolts, Remco H.S. Westerink & Laura Hondebrink. (2017) Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay. Toxicology in Vitro 45, pages 60-71.
Crossref
Crossref
Kazuhiko Kido & Maya Guglin. (2017) Drug-Induced Takotsubo Cardiomyopathy. Journal of Cardiovascular Pharmacology and Therapeutics 22:6, pages 552-563.
Crossref
Crossref
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Crossref
Ritva Karinen & Gudrun Høiseth. (2017) A literature review of blood concentrations of new psychoactive substances classified as phenethylamines, aminoindanes, arylalkylamines, arylcyclohexylamines, and indolalkylamines. Forensic Science International 276, pages 120-125.
Crossref
Crossref
Carl E. Wolf, Justin L. Poklis, Kirk Cumpston, Michael Moss & Alphonse Poklis. (2017) Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion. Drug Testing and Analysis 9:4, pages 657-659.
Crossref
Crossref
Laura Cifuentes & Pedro Amariles. (2017) Miocardiopatía de takotsubo desencadenada por la utilización o exposición a drogas de abuso, sustancias químicas o venenos de origen animal. Revista Colombiana de Cardiología 24:2, pages 117-127.
Crossref
Crossref
Michael S. Toce, Michael Farias, Rebecca Bruccoleri, David W. Brown & Michele M. Burns. (2017) A Case Report of Reversible Takotsubo Cardiomyopathy after Amphetamine/Dextroamphetamine Ingestion in a 15-Year-Old Adolescent Girl. The Journal of Pediatrics 182, pages 385-388.e3.
Crossref
Crossref
Ines Potočnjak, Vesna Degoricija, Dina Vukičević Baudoin, Josip Čulig & Miro Jakovljević. (2016) Cardiovascular side effects of psychopharmacologic therapy. International Journal of Cardiology 219, pages 367-372.
Crossref
Crossref
Justin L. Poklis, Carl E. Wolf & Alphonse Poklis. (2016) 4-Fluoroamphetamine in Serum and Urine from an Intoxicated Patient with Life-Threatening Hyperpyrexia: Table I.. Journal of Analytical Toxicology 40:2, pages 171-172.
Crossref
Crossref
Pertti Heikman, Mira Sundström, Anna Pelander & Ilkka Ojanperä. (2016) New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening. Human Psychopharmacology: Clinical and Experimental 31:1, pages 44-52.
Crossref
Crossref
Johanna J. Nugteren-van Lonkhuyzen, Antoinette J.H.P. van Riel, Tibor M. Brunt & Laura Hondebrink. (2015) Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug and Alcohol Dependence 157, pages 18-27.
Crossref
Crossref
. (2015) Fluoxetine/trazodone. Reactions Weekly 1537:1, pages 132-132.
Crossref
Crossref